Neoprobe Corporation Announces 2008 Results with Record Medical Device Sales

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP) today announced its consolidated financial results for the fourth quarter of 2008 and for the full year ended December 31, 2008. For the fourth quarter of 2008, Neoprobe had a net loss of $1.2 million or $0.02 per share compared to a net loss of $1.9 million or $0.03 per share for the fourth quarter of 2007. For fiscal 2008, Neoprobe incurred a net loss of $5.2 million or $0.08 per share compared to a net loss of $5.1 million or $0.08 per share for fiscal 2007. Neoprobe’s loss from operations for the fourth quarter of 2008 was $755,000 compared to $272,000 for the fourth quarter of 2007. Neoprobe’s loss from operations for the fiscal year ended December 31, 2008 was $3.0 million compared to $1.8 million for fiscal 2007.

MORE ON THIS TOPIC